Bridgeway Capital Management’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-48,000
| Closed | -$384K | – | 1233 |
|
2024
Q3 | $384K | Hold |
48,000
| – | – | 0.01% | 923 |
|
2024
Q2 | $418K | Sell |
48,000
-6,100
| -11% | -$53.1K | 0.01% | 900 |
|
2024
Q1 | $1.12M | Sell |
54,100
-18,900
| -26% | -$391K | 0.02% | 722 |
|
2023
Q4 | $1.69M | Sell |
73,000
-44,100
| -38% | -$1.02M | 0.04% | 640 |
|
2023
Q3 | $936K | Sell |
117,100
-35,000
| -23% | -$280K | 0.02% | 724 |
|
2023
Q2 | $1.32M | Buy |
152,100
+122,100
| +407% | +$1.06M | 0.03% | 668 |
|
2023
Q1 | $88.2K | Buy |
+30,000
| New | +$88.2K | ﹤0.01% | 1260 |
|
2022
Q3 | – | Sell |
-25,900
| Closed | -$204K | – | 1419 |
|
2022
Q2 | $204K | Sell |
25,900
-34,500
| -57% | -$272K | ﹤0.01% | 1087 |
|
2022
Q1 | $734K | Sell |
60,400
-29,900
| -33% | -$363K | 0.01% | 851 |
|
2021
Q4 | $1.11M | Sell |
90,300
-22,520
| -20% | -$276K | 0.02% | 769 |
|
2021
Q3 | $1.18M | Sell |
112,820
-17,000
| -13% | -$177K | 0.02% | 769 |
|
2021
Q2 | $1.17M | Buy |
129,820
+17,501
| +16% | +$157K | 0.02% | 808 |
|
2021
Q1 | $1.14M | Buy |
112,319
+58,400
| +108% | +$593K | 0.02% | 814 |
|
2020
Q4 | $355K | Sell |
53,919
-11,501
| -18% | -$75.7K | 0.01% | 1072 |
|
2020
Q3 | $339K | Sell |
65,420
-6,000
| -8% | -$31.1K | 0.01% | 1021 |
|
2020
Q2 | $541K | Buy |
71,420
+20,500
| +40% | +$155K | 0.01% | 833 |
|
2020
Q1 | $519K | Sell |
50,920
-11,500
| -18% | -$117K | 0.01% | 752 |
|
2019
Q4 | $968K | Buy |
62,420
+9,520
| +18% | +$148K | 0.01% | 747 |
|
2019
Q3 | $957K | Buy |
52,900
+19,000
| +56% | +$344K | 0.01% | 736 |
|
2019
Q2 | $556K | Hold |
33,900
| – | – | 0.01% | 943 |
|
2019
Q1 | $607K | Buy |
33,900
+23,710
| +233% | +$425K | 0.01% | 965 |
|
2018
Q4 | $193K | Hold |
10,190
| – | – | ﹤0.01% | 1223 |
|
2018
Q3 | $364K | Hold |
10,190
| – | – | ﹤0.01% | 1210 |
|
2018
Q2 | $212K | Hold |
10,190
| – | – | ﹤0.01% | 1304 |
|
2018
Q1 | $124K | Hold |
10,190
| – | – | ﹤0.01% | 1311 |
|
2017
Q4 | $110K | Sell |
10,190
-3,200
| -24% | -$34.5K | ﹤0.01% | 1327 |
|
2017
Q3 | $161K | Hold |
13,390
| – | – | ﹤0.01% | 1307 |
|
2017
Q2 | $229K | Sell |
13,390
-6,800
| -34% | -$116K | ﹤0.01% | 1262 |
|
2017
Q1 | $347K | Sell |
20,190
-350
| -2% | -$6.02K | ﹤0.01% | 1175 |
|
2016
Q4 | $351K | Hold |
20,540
| – | – | ﹤0.01% | 1192 |
|
2016
Q3 | $618K | Hold |
20,540
| – | – | 0.01% | 988 |
|
2016
Q2 | $581K | Hold |
20,540
| – | – | 0.01% | 977 |
|
2016
Q1 | $550K | Hold |
20,540
| – | – | 0.01% | 1003 |
|
2015
Q4 | $990K | Hold |
20,540
| – | – | 0.02% | 764 |
|
2015
Q3 | $750K | Hold |
20,540
| – | – | 0.02% | 851 |
|
2015
Q2 | $774K | Buy |
20,540
+350
| +2% | +$13.2K | 0.02% | 888 |
|
2015
Q1 | $798K | Hold |
20,190
| – | – | 0.02% | 888 |
|
2014
Q4 | $830K | Hold |
20,190
| – | – | 0.02% | 843 |
|
2014
Q3 | $892K | Buy |
20,190
+9,700
| +92% | +$429K | 0.02% | 794 |
|
2014
Q2 | $455K | Hold |
10,490
| – | – | 0.01% | 1135 |
|
2014
Q1 | $430K | Hold |
10,490
| – | – | 0.01% | 1141 |
|
2013
Q4 | $416K | Hold |
10,490
| – | – | 0.01% | 1122 |
|
2013
Q3 | $431K | Buy |
10,490
+190
| +2% | +$7.81K | 0.01% | 1101 |
|
2013
Q2 | $399K | Buy |
+10,300
| New | +$399K | 0.02% | 1044 |
|